IBD Flashcards
1
Q
IBD
A
- Inflammatory bowel disease, that is chronic inflammatory disease of the GI tract
- Results in edema, ulceration, and tissue destruction
- Treatment requires flare therapy as well as maintenance therapy that prevents flare reoccurrence
2
Q
IBD s/s
A
Diarrhea, blood in stool, abdominal pain, cramping, weight loss, fatigue, change in daily activities
3
Q
Diagnosis of IBD
A
- Non invasive lab tests (ESR, CRP which are non specific markers of inflammation in the body)
- Stool studies (look for leukocytes in the stool)
- Endoscopy-colonoscopy (can look at entire colon and ileum, very invasive)
- CT/MRI (see if there is penetration of the disease into neighboring organs
4
Q
IBD disease location (UC)
A
- Confined to the rectum (proctitis)
- Inflammation up rectum, sigmoid colon, descending colon and stop at splenic flexure (left sided colitis or distal)
- Inflammation past splenic flexure (extensive disease or pan colitis)
5
Q
UC
A
- superficial inflammation
- confined to mucosa (continuous)
- anal involvement is not common
- patients at risk for megacolon or colon cancer
- Colectomy: removal of colon (cure)
6
Q
IBD disease location (CD)
A
- Anywhere from mouth to anus
- Most common is terminal ileum (2/3 of patients)
- Perianal involvement is common
7
Q
CD
A
- deep
- can go through all layers of intestinal wall
- patchy inflammation, cobblestone appearance
8
Q
CD complications
A
- Malnutrition
- vitamin deficiencies
- strictures
- fistulas
- no cure
9
Q
5-ASA
A
- Mesalamine
- Sulfasalazine
- Balsalazide
- Olsalazine
10
Q
Immunomodulators
A
- Azathioprine
- 6-mercap
- Methotrexate
- Cyclosporine
- Tacrolimus
11
Q
Antibiotics
A
- Metronidazole
- Ciprofloxacin or 3GC
12
Q
Corticosteroids
A
- Prednisone
- Methylprednisolone
- Budesonide
- Hydrocortisone
13
Q
Biologics
A
- Infliximab (UC/CD)
- Adalimumab (UC/CD)
- Certolizumab (CD)
- Golimumab (UD)
- Natalizumab (CD)
- Vedolizumab (UC/CD)
- Ustekinumab (UC/CD)
- Tofacitinib (UC)
14
Q
5-ASA
A
- act topically to reduce inflammation in GI tract
- have to get to intestinal sire to work, have to modify drug delivery to get to site.
15
Q
Sulfasalazine
A
- Sulfa is carrier
- Mesalamine is active component
- Sulfa is responsible for ADR: GI, rash, photosensitivity, blood dycrasias
16
Q
Olsalazine
A
- 2 ASA molecules linked together and cleaved apart by gut bacteria in colon
- better tolerated than sulfasal but high diarrhea rate
17
Q
Balsalazide
A
- Sulfasalazine without sulfa
- lots of drug to take
18
Q
Mesalamine products
A
- not used in CD
- supp can only penetrate rectum
- enema can penetrate all the way to splenic flexure
- PO products will release somewhere in small or large intestine
19
Q
Immunomodulators
A
maintain therapy remission